• Jazz Pharmaceuticals average debt/equity ratio for 2023 was 1.54, a 17.2% decline from 2022.
• Jazz Pharmaceuticals average debt/equity ratio for 2022 was 1.86, a 44.19% decline from 2021.
• Jazz Pharmaceuticals average debt/equity ratio for 2021 was 1.29, a 126.32% increase from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.